feed,title,long_url,short_url
SA,[ew] Edwards Lifesciences outlines 8%–10% sales growth and $2.90–$3.05 EPS guidance for 2026 while advancing SAPIEN and TMTT platforms,https://seekingalpha.com/news/4549916,
